"M. Forte to" She reviews her latest research at Abu Dhabi International Health Care Week
Abu Dhabi, April 16 / WAM / Dr. Mai Al -Jaber, CEO of the Foreign Clinic Group at M.F. Forte To Healthcare, confirmed that the group’s participation in the Abu Dhabi International Health Care Week comes within the framework of her keenness to review its latest research and medical services, through its subsidiary institutions, including the Imperial College London Diabetes Center, Murphield Eye Hospital, Health Plus centers For endocrine and diabetes, and family medicine clinics.
Al -Jaber explained on this occasion that the group focuses on integrating technology and artificial intelligence into the health care system to provide specialized medical services designed to meet the needs of each patient separately, thanks to medical cadres with international experiences in accurate specializations for diabetes and endocrine fields.
She referred to international cooperation with the Murfields Eye Center in the United States, as part of exchanging experiences and developing the level of care.
For his part, Dr. Imad George, Diabetes and Endocrine Consultant at the Imperial College London Diabetes Center, said that “Health Week” is an important platform to display the latest technologies and enhance communication with the global medical community.
He added that the Imperial College Center is based on three main pillars: clinical research, clinical care, and education, explaining that its services are not limited to the treatment of diabetes and endocrine, but also include obesity surgeries, comprehensive health care for women, and the treatment of gland disorders such as thyroid and pituitary.
In the same context, Dimitrs Mogafasilis, CEO of World Patient Welfare Services at M.Forte Tou, announced the signing of a strategic agreement with the Gavininsense Group, noting that the agreement represents a new start in the field of life sciences, through the use of apparent and generous data in support of the discovery of medicines, and the use of artificial intelligence in leading genome projects, to provide innovative treatments based on advanced analysis For data.
- For more: Follow Khaleejion 24 Arabic, Khaleejion 24 English, Khaleejion 24 Live, and for social media follow us on Facebook and Twitter
